Methods for reducing oxidative damage

Details for Australian Patent Application No. 2005208821 (hide)

Owner Cornell Research Foundation, Inc.

Inventors Szeto, Hazel H.

Agent Fisher Adams Kelly

Pub. Number AU-B-2005208821

PCT Pub. Number WO2005/072295

Priority 60/538,841 23.01.04 US

Parent 2004209663

Filing date 21 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 30 September 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 38/07 (2006.01) Medicinal preparations containing peptides - Tetrapeptides

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/103 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/107 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/11 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/117 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072295 Priority application(s): WO2005/072295

2 November 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Oct 2006

30 September 2010 Application Accepted

  Published as AU-B-2005208821

14 October 2010 Corrigenda

  Applications Accepted - Name Index Under the name Cornell Research Foundation, Inc., Application No. 2005208821, under INID (31) remove 60/538,841, under INID remove 23 January 2004, under INID remove US

27 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005208832-Reelin deficiency or dysfunction and methods related thereto

2005208820-Glaucoma treatment method